Izoksuprin
![]() | |
Nazivi | |
---|---|
IUPAC naziv 4-{1-hidroksi-2-[(1-metil-2-fenoksietil)amino]propil}fenol | |
Drugi nazivi Vasodilian, Duvadilan | |
Identifikacija | |
| |
3D model (Jmol) |
|
ChemSpider |
|
ECHA InfoCard | 100.006.272 |
KEGG[2] |
|
MeSH | Isoxsuprine |
| |
SMILES
| |
Svojstva | |
C18H23NO3 | |
Molarna masa | 301,38012 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
![]() ![]() ![]() | |
Reference infokutije | |
Izoksuprin (Izoksuprin hidrohlorid, Vasodilan) je lek koji se koristi kao vazodilatator[5] kod ljudi. Izoksuprin je beta-adrenergički agonist koji uzrokuje direktnu relaksaciju materičnih i vaskularnih glatkih mišića putem beta-2 receptora.[6]
Reference
- ^ Isoxsuprine - Compound Summary, PubChem.
- ^ Joanne Wixon; Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast. 17 (1): 48—55. doi:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Gozo EG, Yebes RB (1984). „Hemodynamic effects of isoxsuprine in cardiac failure”. Chest. 86 (5): 736—40. PMID 6488912. doi:10.1378/chest.86.5.736. [мртва веза]
- ^ Falkay, G.; Kovács, L. (1986). „Affinity of tocolytic agents on human placental and myometrial beta-adrenergic receptors”. Journal of perinatal medicine. 14 (2): 109—113. PMID 2874205.
Literatura
- Forney, Barbara C, MS, VMD. Equine Medications, Revised Edition. Blood Horse Publications. Lexington, KY. Copyright 2007.
- п
- р
- у
|
|
|
Drugi | |||||||
---|---|---|---|---|---|---|---|
|